Dean T Nora
Overview
Explore the profile of Dean T Nora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
121
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Turner R, Nora D, Trocha S, Bilchik A
Arch Pathol Lab Med
. 2003 May;
127(6):673-9.
PMID: 12741889
Context: Nodal staging accuracy is important for prognosis and selection of patients for chemotherapy. Sentinel lymph node (SLN) mapping improves staging accuracy in breast cancer and melanoma and is being...
2.
Trocha S, Nora D, Saha S, Morton D, Wiese D, Bilchik A
J Gastrointest Surg
. 2003 Mar;
7(3):340-5; discussion 345-6.
PMID: 12654558
Nodal metastasis is the single most important prognostic factor in early colorectal cancer (CRC). Lymphatic mapping can identify sentinel nodes for focused histopathologic examination and thereby improve the nodal staging...
3.
Bilchik A, Nora D, Sobin L, Turner R, Trocha S, Krasne D, et al.
J Clin Oncol
. 2003 Feb;
21(4):668-72.
PMID: 12586804
Purpose: Sensitive detection methods and accurate reporting are necessary to determine the prognostic significance of micrometastases (MM) and isolated tumor cells (ITCs) in lymph nodes that drain colorectal cancers (CRCs)....
4.
Bleicher R, Allegra D, Nora D, Wood T, Foshag L, Bilchik A
Ann Surg Oncol
. 2003 Jan;
10(1):52-8.
PMID: 12513961
Background: Radiofrequency ablation (RFA) is a promising technique for unresectable hepatic malignancies. We reviewed our RFA experience to identify variables affecting local recurrence. Methods: Patients undergoing RFA between 1997 and...
5.
Bilchik A, Nora D, Saha S, Turner R, Wiese D, Kuo C, et al.
Arch Surg
. 2002 Dec;
137(12):1377-83.
PMID: 12470104
Background: Approximately one third of node-negative colorectal cancers (CRCs) recur, suggesting the failure to detect occult disease. Lymphatic mapping followed by focused analysis of the sentinel node is highly accurate...
6.
7.
Wood T, Nora D, Morton D, Turner R, Rangel D, Hutchinson W, et al.
J Gastrointest Surg
. 2002 May;
6(3):322-9; discussion 229-30.
PMID: 12022982
Almost one third of patients with "node-negative" colorectal carcinoma (CRC) develop systemic disease. This implies that these patients have occult disease that is inadequately treated by surgery alone. We have...